MALARONE PEDIATRIC
MALARONE PEDIATRIC
Approved
DIN Number
02264935
Drug Class
Human
Market Date
May 17, 2005
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02264935
AIG Number0250721001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
P01BB51 PROGUANIL AND ATOVAQUONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:30.92
Health Canada Classification
ACTIVE INGREDIENTS (2)
ATOVAQUONEActive
Strength: 62.5 MG
Monograph: ATOVAQUONE
PROGUANIL HYDROCHLORIDEActive
Strength: 25.0 MG
Monograph: PROGUANIL HYDROCHLORIDE